Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-24

FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental NDA for ATACAND (candesartan cilexetil), resulting in an updated product label. This action pertains to a sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacand (candesartan)

Snippet

SUPPL AP for ATACAND (CANDESARTAN CILEXETIL)